Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.

Saved in:
Bibliographic Details
Title: Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
Authors: Angotzi F; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Lessi F; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Leoncin M; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venice, Italy., Filì C; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy., Endri M; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, Treviso, Italy., Lico A; Hematology and Cell Therapy Division, San Bortolo Hospital, Vicenza, Italy., Visentin A; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Pravato S; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Candoni A; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy., Trentin L; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy., Gurrieri C; Hematology Unit, Azienda Ospedale-Università and University of Padova, Padua, Italy.
Source: Frontiers in oncology [Front Oncol] 2024 Apr 12; Vol. 14, pp. 1370405. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1370405